A Nutrition Intervention for Arthritis -3 (WCCR-ARTH3)

NCT ID: NCT03417648

Last Updated: 2019-03-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

8 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-03-08

Study Completion Date

2018-12-14

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to assess whether, in individuals with rheumatoid arthritis, a low-fat, vegan diet improves pain and other subjective symptoms more effectively than a control supplement or a placebo. The principal measure is pain as measured by Visual Analog Scale (VAS) and disease activity as measured by number of painful swollen and tender joints, respectively. The study duration is 36 weeks.

This study tests that a low fat, plant-based (vegan) diet free of foods commonly identified as triggers improves mood, using the Center for Epidemiologic Studies Depression Scale-Revised (CESD-R), and the Beck Depression Inventory II (BDI-II).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Preliminary evidence suggests that low-fat, vegetarian diets and certain nutritional supplements can help reduce pain and also reduce the need for pain medications for some people. The investigators will ask about 100 people to participate. All of them will get a low-fat, vegan diet and a nutritional supplement (mixture of omega-3 oils and vitamin E or a placebo), although some will get the diet first, and others will get the supplement first. This order in which they will get the diet and the supplement will be determined randomly, that is, by chance (like the toss of a coin). The principal measure is pain as measured by Visual Analog Scale (VAS) and disease activity as measured by number of painful swollen and tender joints, respectively. The Beck Depression Inventory II (BDI-II)will be used to measure changes in mood. The study duration is 36 weeks.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rheumatoid Arthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Plant-based diet

The diet group will be asked to follow a low-fat, vegan diet for 16 weeks

Group Type EXPERIMENTAL

Plant-based diet

Intervention Type OTHER

Weekly instructions will be given to the participants in the intervention group about following vegan diet.

Supplement

The supplement group will follow an unrestricted diet, but will be given a pill containing a small, clinically insignificant amount of omega- 3 oils and vitamin E, which will serve as a placebo.

Group Type PLACEBO_COMPARATOR

Supplement

Intervention Type OTHER

unrestricted diet with clinically insignificant amount of omega- 3 oils and vitamin E

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Plant-based diet

Weekly instructions will be given to the participants in the intervention group about following vegan diet.

Intervention Type OTHER

Supplement

unrestricted diet with clinically insignificant amount of omega- 3 oils and vitamin E

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Vitamin E

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* A diagnosis of rheumatoid arthritis based on 2010 ACR / EULAR Rheumatoid Arthritis Classification Criteria. Classification as "definite RA" is based on:
* the confirmed presence of synovitis in at least 1 joint
* absence of an alternative diagnosis that better explains the synovitis
* and achievement of a total score of 6 or greater (of a possible 10): 24 Joint involvement, designating the metacarpophalangeal joints, proximal interphalangeal joints, the interphalangeal joint of the thumb, second through third metatarsophalangeal joint and wrist as small joints, and elbows, hip joints and knees as large joints:

1. Involvement of 1 large joint gives 0 points
2. Involvement of 2-10 large joints gives 1 point
3. Involvement of 1-3 small joints (with or without involvement of large joints) gives 2 points
4. Involvement of 4-10 small joints (with or without involvement of large joints) gives 3 points
5. Involvement of more than 10 joints (with involvement of at least 1 small joint) gives 5 points
* Serological parameters - including the rheumatoid factor as well as anti-citrullinated protein antibody (ACPA):

1. Negative RF and negative ACPA gives 0 points
2. Low-positive RF or low-positive ACPA gives 2 points
3. High-positive RF or high-positive ACPA gives 3 points Acute phase reactants: 1 point for elevated erythrocyte sedimentation rate (ESR) or elevated C-reactive protein (CRP) value Duration of arthritis: 1 point for symptoms lasting six weeks or longer
* Continuing or recurring pain (i.e., joint pain daily, unless on pain medication).
* Age at least 18 years
* Ability and willingness to participate in all components of the study
* Willingness to be assigned to either the diet group or supplement group
* Pain medications unchanged within last 6 weeks.

Exclusion Criteria

* \< 18 years of age
* Alcohol consumption of more than 2 drinks per day or the equivalent, episodic increased drinking (e.g., more than 2 drinks per day on weekends), or a history of alcohol abuse or dependency followed by any current use
* Use of recreational drugs in the past 6 months (past drug use, if fully recovered, is not a criteria for exclusion)
* Pregnancy
* Unstable medical or psychiatric illness
* Likely to be disruptive in group sessions (as determined by research staff)
* Already following a low-fat, vegan diet
* Lack of English fluency
* Inability to maintain current medication regimen
* Inability or unwillingness to participate in all components of the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Physicians Committee for Responsible Medicine

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Neal D Barnard

Role: PRINCIPAL_INVESTIGATOR

Physicians Committee for Responsible Medicine

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Physicians Committee for Responsible Medicine

Washington D.C., District of Columbia, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Barnard ND, Levin S, Crosby L, Flores R, Holubkov R, Kahleova H. A Randomized, Crossover Trial of a Nutritional Intervention for Rheumatoid Arthritis. Am J Lifestyle Med. 2022 Apr 3;19(2):266-275. doi: 10.1177/15598276221081819. eCollection 2025 Feb.

Reference Type DERIVED
PMID: 39981557 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

WCCR-ARTH-3

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Nutrition in Rheumatoid Arthritis
NCT06831331 ENROLLING_BY_INVITATION NA
Evaluation of Walk With Ease in Arthritis
NCT00526435 COMPLETED PHASE3